US Stock MarketDetailed Quotes

MRSN Mersana Therapeutics

Watchlist

3.460
+0.100+2.98%

Close May 3 16:00 ET

3.580
+0.120+3.47%

Post 17:36 ET

423.37MMarket Cap-2337P/E (TTM)

Mersana Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-242.12%-168.88M

37.61%-31.96M

-184.40%-46.08M

-38.10%-61.83M

-264.61%-29.01M

64.74%-49.36M

-20.82%-51.23M

251.25%54.6M

-29.91%-44.78M

70.56%-7.96M

Net income from continuing operations

15.94%-171.67M

56.50%-19.54M

30.35%-41.66M

-4.00%-54.31M

-18.84%-56.16M

-20.08%-204.21M

8.29%-44.92M

-31.54%-59.81M

-27.63%-52.22M

-36.22%-47.26M

Depreciation and amortization

63.65%1.52M

58.51%447K

100.47%427K

42.73%324K

55.61%319K

8.42%927K

33.65%282K

0.47%213K

10.19%227K

-9.29%205K

Other non cash items

-2.06%3.47M

-1.18%2.93M

12.44%217K

-10.70%167K

-21.65%152K

389.63%3.54M

391.06%2.97M

359.52%193K

379.49%187K

410.53%194K

Change In working capital

-114.40%-18.76M

-41.66%-19.55M

-107.37%-8.02M

-821.62%-12.88M

-35.09%21.69M

1,192.24%130.32M

-1,619.93%-13.8M

2,498.88%108.92M

10.32%1.79M

892.25%33.42M

-Change in receivables

200.00%30M

--0

--30M

---30M

--0

-Change in prepaid assets

-8.52%3.53M

169.09%3.78M

-14.31%1.75M

-396.48%-2.61M

234.20%620K

241.29%3.86M

2.48%1.4M

221.00%2.04M

137.00%881K

-1,148.65%-462K

-Change in payables and accrued expense

-285.79%-27.02M

-927.21%-12.74M

-164.99%-8.11M

-110.88%-566K

-19.56%-5.6M

11.40%14.54M

372.57%1.54M

196.51%12.48M

9.72%5.2M

-200.36%-4.68M

-Change in other current assets

--0

3.57%-2.05M

11.51%707K

11.75%675K

-24.75%669K

--0

-1,281.67%-2.13M

-71.88%634K

261.93%604K

193.48%889K

-Change in other current liabilities

-75.49%-3.14M

-1,467.14%-957K

-15.56%-765K

-16.77%-724K

-20.38%-697K

-37.56%-1.79M

206.06%70K

-14.93%-662K

-71.75%-620K

-93.65%-579K

-Change in other working capital

-115.41%-22.14M

-149.52%-7.58M

-101.70%-1.6M

-125.35%-9.65M

-108.63%-3.3M

334,306.98%143.71M

139,300.00%15.31M

858,527.27%94.43M

-42,740.00%-4.28M

347,863.64%38.25M

Cash from discontinued investing activities

Operating cash flow

-242.12%-168.88M

37.61%-31.96M

-184.40%-46.08M

-38.10%-61.83M

-264.61%-29.01M

64.74%-49.36M

-20.82%-51.23M

251.25%54.6M

-29.91%-44.78M

70.56%-7.96M

Investing cash flow

Cash flow from continuing investing activities

178.50%119.88M

144.35%20.15M

729.30%103.78M

93.99%-5.44M

524.32%1.4M

-23,467.28%-152.72M

-29,207.10%-45.43M

-35,750.00%-16.49M

-27,068.17%-90.47M

-188.60%-329K

Net PPE purchase and sale

1.32%-2.17M

50.83%-386K

-10.80%-472K

39.27%-399K

-176.90%-911K

-239.04%-2.2M

-406.45%-785K

-826.09%-426K

-97.30%-657K

-188.60%-329K

Net investment purchase and sale

181.09%122.05M

146.00%20.53M

748.93%104.25M

94.39%-5.04M

--2.31M

---150.52M

---44.64M

---16.07M

---89.81M

--0

Cash from discontinued investing activities

Investing cash flow

178.50%119.88M

144.35%20.15M

729.30%103.78M

93.99%-5.44M

524.32%1.4M

-23,467.28%-152.72M

-29,207.10%-45.43M

-35,750.00%-16.49M

-27,068.17%-90.47M

-188.60%-329K

Financing cash flow

Cash flow from continuing financing activities

-38.13%94.68M

-99.78%92K

-101.37%-146K

80.57%73.18M

-64.32%21.55M

140.42%153.02M

43.98%41.46M

2,197.62%10.64M

19.49%40.53M

12,695.34%60.39M

Net issuance payments of debt

-51.47%-412K

-232.31%-216K

0.00%-65K

0.00%-66K

14.47%-65K

-101.48%-272K

-100.35%-65K

0.00%-65K

-60.98%-66K

-130.30%-76K

Net common stock issuance

-38.01%93.54M

--0

-100.76%-81K

79.78%71.89M

-64.01%21.73M

250.21%150.89M

307.54%39.94M

20,870.59%10.59M

19.94%39.99M

--60.37M

Proceeds from stock option exercised by employees

-35.39%1.55M

-90.03%158K

--0

123.76%1.36M

-64.58%34K

-3.27%2.4M

207.57%1.58M

-81.00%110K

-2.10%606K

-87.43%96K

Net other financing activities

----

--0

---150K

----

Cash from discontinued financing activities

Financing cash flow

-38.13%94.68M

-99.78%92K

-101.37%-146K

80.57%73.18M

-64.32%21.55M

140.42%153.02M

43.98%41.46M

2,197.62%10.64M

19.49%40.53M

12,695.34%60.39M

Net cash flow

Beginning cash position

-27.50%129.36M

1.19%186.76M

-4.86%129.21M

-46.51%123.3M

-27.50%129.36M

-30.14%178.43M

-3.97%184.56M

-40.40%135.82M

0.78%230.54M

-30.14%178.43M

Current changes in cash

193.10%45.68M

78.76%-11.72M

18.07%57.55M

106.24%5.91M

-111.63%-6.06M

36.27%-49.06M

-301.14%-55.2M

236.61%48.74M

-10,602.71%-94.72M

295.43%52.11M

End cash Position

35.31%175.04M

1.19%186.76M

-4.86%129.21M

-46.51%123.3M

-27.50%129.36M

-3.97%184.56M

-40.40%135.82M

0.78%230.54M

Free cash flow

-231.75%-171.05M

37.81%-32.35M

-185.94%-46.55M

-36.98%-62.23M

-261.13%-29.92M

63.34%-51.56M

-22.23%-52.01M

249.88%54.17M

-30.55%-45.43M

69.47%-8.28M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-242.12%-168.88M	37.61%-31.96M	-184.40%-46.08M	-38.10%-61.83M	-264.61%-29.01M	64.74%-49.36M	-20.82%-51.23M	251.25%54.6M	-29.91%-44.78M	70.56%-7.96M
Net income from continuing operations	15.94%-171.67M	56.50%-19.54M	30.35%-41.66M	-4.00%-54.31M	-18.84%-56.16M	-20.08%-204.21M	8.29%-44.92M	-31.54%-59.81M	-27.63%-52.22M	-36.22%-47.26M
Depreciation and amortization	63.65%1.52M	58.51%447K	100.47%427K	42.73%324K	55.61%319K	8.42%927K	33.65%282K	0.47%213K	10.19%227K	-9.29%205K
Other non cash items	-2.06%3.47M	-1.18%2.93M	12.44%217K	-10.70%167K	-21.65%152K	389.63%3.54M	391.06%2.97M	359.52%193K	379.49%187K	410.53%194K
Change In working capital	-114.40%-18.76M	-41.66%-19.55M	-107.37%-8.02M	-821.62%-12.88M	-35.09%21.69M	1,192.24%130.32M	-1,619.93%-13.8M	2,498.88%108.92M	10.32%1.79M	892.25%33.42M
-Change in receivables	200.00%30M	--0	--0	--0	--30M	---30M	---30M	--0	--0	--0
-Change in prepaid assets	-8.52%3.53M	169.09%3.78M	-14.31%1.75M	-396.48%-2.61M	234.20%620K	241.29%3.86M	2.48%1.4M	221.00%2.04M	137.00%881K	-1,148.65%-462K
-Change in payables and accrued expense	-285.79%-27.02M	-927.21%-12.74M	-164.99%-8.11M	-110.88%-566K	-19.56%-5.6M	11.40%14.54M	372.57%1.54M	196.51%12.48M	9.72%5.2M	-200.36%-4.68M
-Change in other current assets	--0	3.57%-2.05M	11.51%707K	11.75%675K	-24.75%669K	--0	-1,281.67%-2.13M	-71.88%634K	261.93%604K	193.48%889K
-Change in other current liabilities	-75.49%-3.14M	-1,467.14%-957K	-15.56%-765K	-16.77%-724K	-20.38%-697K	-37.56%-1.79M	206.06%70K	-14.93%-662K	-71.75%-620K	-93.65%-579K
-Change in other working capital	-115.41%-22.14M	-149.52%-7.58M	-101.70%-1.6M	-125.35%-9.65M	-108.63%-3.3M	334,306.98%143.71M	139,300.00%15.31M	858,527.27%94.43M	-42,740.00%-4.28M	347,863.64%38.25M
Cash from discontinued investing activities
Operating cash flow	-242.12%-168.88M	37.61%-31.96M	-184.40%-46.08M	-38.10%-61.83M	-264.61%-29.01M	64.74%-49.36M	-20.82%-51.23M	251.25%54.6M	-29.91%-44.78M	70.56%-7.96M
Investing cash flow
Cash flow from continuing investing activities	178.50%119.88M	144.35%20.15M	729.30%103.78M	93.99%-5.44M	524.32%1.4M	-23,467.28%-152.72M	-29,207.10%-45.43M	-35,750.00%-16.49M	-27,068.17%-90.47M	-188.60%-329K
Net PPE purchase and sale	1.32%-2.17M	50.83%-386K	-10.80%-472K	39.27%-399K	-176.90%-911K	-239.04%-2.2M	-406.45%-785K	-826.09%-426K	-97.30%-657K	-188.60%-329K
Net investment purchase and sale	181.09%122.05M	146.00%20.53M	748.93%104.25M	94.39%-5.04M	--2.31M	---150.52M	---44.64M	---16.07M	---89.81M	--0
Cash from discontinued investing activities
Investing cash flow	178.50%119.88M	144.35%20.15M	729.30%103.78M	93.99%-5.44M	524.32%1.4M	-23,467.28%-152.72M	-29,207.10%-45.43M	-35,750.00%-16.49M	-27,068.17%-90.47M	-188.60%-329K
Financing cash flow
Cash flow from continuing financing activities	-38.13%94.68M	-99.78%92K	-101.37%-146K	80.57%73.18M	-64.32%21.55M	140.42%153.02M	43.98%41.46M	2,197.62%10.64M	19.49%40.53M	12,695.34%60.39M
Net issuance payments of debt	-51.47%-412K	-232.31%-216K	0.00%-65K	0.00%-66K	14.47%-65K	-101.48%-272K	-100.35%-65K	0.00%-65K	-60.98%-66K	-130.30%-76K
Net common stock issuance	-38.01%93.54M	--0	-100.76%-81K	79.78%71.89M	-64.01%21.73M	250.21%150.89M	307.54%39.94M	20,870.59%10.59M	19.94%39.99M	--60.37M
Proceeds from stock option exercised by employees	-35.39%1.55M	-90.03%158K	--0	123.76%1.36M	-64.58%34K	-3.27%2.4M	207.57%1.58M	-81.00%110K	-2.10%606K	-87.43%96K
Net other financing activities	----	----	--0	--0	---150K	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-38.13%94.68M	-99.78%92K	-101.37%-146K	80.57%73.18M	-64.32%21.55M	140.42%153.02M	43.98%41.46M	2,197.62%10.64M	19.49%40.53M	12,695.34%60.39M
Net cash flow
Beginning cash position	-27.50%129.36M	1.19%186.76M	-4.86%129.21M	-46.51%123.3M	-27.50%129.36M	-30.14%178.43M	-3.97%184.56M	-40.40%135.82M	0.78%230.54M	-30.14%178.43M
Current changes in cash	193.10%45.68M	78.76%-11.72M	18.07%57.55M	106.24%5.91M	-111.63%-6.06M	36.27%-49.06M	-301.14%-55.2M	236.61%48.74M	-10,602.71%-94.72M	295.43%52.11M
End cash Position	35.31%175.04M	35.31%175.04M	1.19%186.76M	-4.86%129.21M	-46.51%123.3M	-27.50%129.36M	-27.50%129.36M	-3.97%184.56M	-40.40%135.82M	0.78%230.54M
Free cash flow	-231.75%-171.05M	37.81%-32.35M	-185.94%-46.55M	-36.98%-62.23M	-261.13%-29.92M	63.34%-51.56M	-22.23%-52.01M	249.88%54.17M	-30.55%-45.43M	69.47%-8.28M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall